Nymox Pharmaceutical NYMXF
OTC NYMXF
$0.03 -0.01 (-25.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

Nymox Pharmaceutical (NYMXF) Capital Expenditures (2018 - 2023)

Updated

Nymox Pharmaceutical's Capital Expenditures came in at -$1,000 for FY2025.

Analysis

Nymox Pharmaceutical (NYMXF) Capital Expenditures (2018 - 2023) Analysis & Trends

Going back to FY2016, Nymox Pharmaceutical's Capital Expenditures data covers 6 years.

  • The FY2025 figure represents the highest annual Capital Expenditures since FY2021.
  • Per Business Quant, earlier years put Capital Expenditures at -$3,000 in FY2023 and $6,000 in FY2021 (-53.8%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,155.80 Bn 1,124.39 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 630.65 Bn 549.18 Bn 17.26 Bn 1.32 Bn
3 AbbVie 502.74 Bn 475.85 Bn 12.70 Bn 322.00 Mn
4 Merck 375.34 Bn 329.72 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 301.36 Bn 265.35 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 265.02 Bn 238.70 Bn 12.86 Bn 1.86 Bn
7 Amgen 239.16 Bn 194.55 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 192.63 Bn 166.82 Bn 6.22 Bn 140.00 Mn
9 Pfizer 171.82 Bn 118.47 Bn 10.94 Bn 533.00 Mn
10 Nymox Pharmaceutical 3.06 Mn 2.87 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -6,000.00
Mar 31, 2023 3,000.00
Dec 31, 2021 4,000.00
Mar 31, 2021 2,000.00
Dec 31, 2020 12,000.00
Sep 30, 2020 1,000.00
Dec 31, 2018 47,000.00
API Access

Nymox Pharmaceutical Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=NYMXF&period=max&api_key=YOUR_API_KEY